Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control

Inflammation

Volumn 37, Issue 2, 2014, Pages 349-357

  Fronczyk, Aneta ^a   Molęda, Piotr ^a   Safranow, Krzysztof ^a   Piechota, Wiesław ^b   Majkowska, Lilianna ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

CRP; microvascular and macrovascular complications; obesity; type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC CONTROL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SENSITIVITY ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 84896324646     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9746-4     Document Type: Article

References (37)

1. Bray, G.A.; M.B. Clearfield, D.J. Fintel, and D.S. Nelinson. 2009. Overweight and obesity: The pathogenesis of cardiometabolic risk. Clinical Cornerstone 9(4): 30-40. discussion 41-42.
2. Garcia, C.; B. Feve, P. Ferré, et al. 2010. Diabetes and inflammation: Fundamental aspects and clinical implications. Diabetes & Metabolism 36(5): 327-338.
3. Pepys, M.B.; and G.M. Hirschfield. 2003. C-reactive protein: A critical update. Journal of Clinical Investigation 111: 1805-1812.
4. Yosef-Levi, I.M.; E. Grad, and H.D. Danenberg. 2007. C-reactive protein and atherothrombosis - a prognostic factor or a risk factor? Harefuah 146(12): 970-974.
5. Kahn, S.E.; B. Zinman, S.M. Haffner, et al. 2006. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55(8): 2357-2364.
6. Park, J.S.; M.H. Cho, J.S. Nam, et al. 2010. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetologica 47(2): 113-118.
7. Belfki, H.; S. Ben Ali, S. Bougatef, et al. 2012. Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation 35(2): 684-689.
8. Mahajan, A.; R. Tabassum, S. Chavali, et al. 2009. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. Journal of Clinical Endocrinology and Metabolism 94(6): 2123-2127.
9. Lu, B.; Y. Yang, Z. Yang, et al. 2010. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovascular Diabetology 9: 92.
10. Kanai, A.; T. Kawamura, T. Umemura, et al. 2008. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 82(2): 157-164.
11. Pu, L.J.; L. Lu, X.W. Xu, et al. 2006. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 5: 27.
12. Cox, A.J.; S. Agarwal, D. M Herrington, J.J. Carr, B.I. Freedman, and D.W. Bowden. 2012. C-reactive protein concentration predicts mortality in type 2 diabetes: The Diabetes Heart Study. Diabetic Medicine 29(6): 767-770.
13. Su, G.; S. Mi, H. Tao, et al. 2011. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 10: 19.
14. Jin, C.; L. Lu, R.Y. Zhang, et al. 2009. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clinica Chimica Acta 408(1-2): 45-49.
15. Lau, D.C.; B. Dhillon, H. Yan, P.E. Szmitko, and S. Verma. 2005. Adipokines: Molecular links between obesity and atherosclerosis. American Journal of Physiology. Heart and Circulatory Physiology 288(5): 2031-2041.
16. Pasceri, V.; J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18): 2165-2168.
17. Abrahamian, H.; G. Endler, M. Exner, et al. 2007. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Experimental and Clinical Endocrinology and Diabetes 115(1): 38-41.
18. Festa, A.; R. D'Agostino, G. Howard, L. Mykkänen, R.P. Tracy, and S.M. Haffner. 2000. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney International 58(4): 1703-1710.
19. Navarro, J.F.; C. Mora, M. Maca, and J. Garca. 2003. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases 42(1): 53-61.
20. Del Cañizo Gómez, F.J.; C. Fernández Pérez, I. Moreno Ruiz, et al. 2011. Microvascular complications and the risk factors in patients with type 2 diabetes. Endocrinología y Nutrición 58(4): 163-168.
21. Nowak, M.; T. Wielkoszyński, B. Marek, et al. 2010. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clinical and Experimental Medicine 10(3): 185-192.
22. Anan, F.; T. Masaki, Y. Umeno, et al. 2007. Correlations of high-sensitivity C-reactive protein and atherosclerosis in Japanese type 2 diabetes patients. European Journal of Endocrinology 157(3): 311-317.
23. Gustavsson, C.G.; and C.D. Agardh. 2004. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. European Heart Journal 25(23): 2120-2124.
24. Huffman, F.; S. Whisner, G.G. Zarini, and S. Nath. 2010. Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes. International Journal of Environmental Research and Public Health 7(3): 842-852.
25. Pfützner, A.; E. Standl, H.J. Strotmann, et al. 2006. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine 44(5): 556-560.
26. Streja, D.; P. Cressey, and S.W. Rabkin. 2003. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 17(3): 120-127.
27. Trayhurn, P.; and I.S. Wood. 2004. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 92(3): 347-355.
28. Weisberg, S.P.; D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112(12): 1796-1808.
29. Sam, S.; S. Haffner, M.H. Davidson, et al. 2009. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 32(5): 932-937.
30. Miao, C.Y.; and Z.Y. Li. 2012. The role of perivascular adipose tissue in vascular smooth muscle cell growth. British Journal of Pharmacology 165(3): 643-658.
31. Mojiminiyi, O.A.; N. Abdella, M.A. Moussa, A.O. Akanji, H. Mohammedi, and M. Zaki. 2002. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 58(1): 37-44.
32. Prasad, K. 2006. C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews 24(1): 33-50.
33. Palmas, W.; S. Ma, B. Psaty, D.C. Goff Jr.; C. Darwin, and R.G. Barr. 2007. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis. American Journal of Hypertension 20(3): 233-241.
34. Sathyapalan, T.; S.L. Atkin, and E.S. Kilpatrick. 2010. Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetes. Diabetes Care 33(9): 1948-1950.
35. Bahceci, M.; A. Tuzcu, C. Ogun, N. Canoruc, K. Iltimur, and C. Aslan. 2005. Is serum CRP concentration correlated with HbA1c and insulin resistance in type 2 diabetic men with or without coronary heart disease? Journal of Endocrinological Investigation 28(2): 145-150.
36. King, D.E.; A.G. Mainous 3rd, T.A. Buchanan, and W.S. Pearson. 2003. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26(5): 1535-1539.
37. Pradhan, A.D.; B.M. Everett, N.R. Cook, N. Rifai, and P.M. Ridker. 2009. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: The LANCET randomized trial. JAMA 302(11): 1186-1194.